Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D11 OTHER DERMATOLOGICAL PREPARATIONS
D11A OTHER DERMATOLOGICAL PREPARATIONS
D11AX Other dermatologicals
D11AX16 Eflornithine
D00829 Eflornithine hydrochloride (USAN) <US>
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX79 Eflornithine
D00829 Eflornithine hydrochloride (USAN) <US>
P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
P01 ANTIPROTOZOALS
P01C AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS
P01CX Other agents against leishmaniasis and trypanosomiasis
P01CX03 Eflornithine
D00829 Eflornithine hydrochloride (USAN) <US>
USP drug classification [BR:br08302]
Dermatological Agents
Dermatological Agents, Other
Dermatological Agents, Miscellaneous
Eflornithine
D00829 Eflornithine hydrochloride (USAN)
Target-based classification of drugs [BR:br08310]
Enzymes
Lyases (EC4)
Carboxy-lyases
ODC1
D00829 Eflornithine hydrochloride (USAN) <US>
Antimicrobials [BR:br08307]
Antiparasitics
Agents against Leishmaniasis and Trypanosomiasis
Others
D00829 Eflornithine hydrochloride (USAN) <US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D00829